Tue, Sep 16, 2014, 6:47 AM EDT - U.S. Markets open in 2 hrs 43 mins


% | $
Quotes you view appear here for quick access.

Kinder Morgan Energy Partners, L.P. Message Board

  • rlp2451 rlp2451 Oct 19, 2011 2:12 PM Flag

    KMI vs. KMP

    If you were buying today, which one would you buy and why?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Misread your question. KMI is the buy. Still upside to the Goldman price target of $32 and a decent 4%+ qualified yield. But again it is up from $23.66 August low to $28.70 now, a 21% run up.

    • I would not be buying now. KMR hit $54.66 on the close 8/8/11 and is now $66.33, more than $11.50 higher -- that's 10 quarters of stock dividends higher. KMP same thing with a $64.58 August low and a $76.36 price now. The price you pay for a stock is the best way to control you risk. These are toasty highs for KMR/KMP, I'd wait.

      KMR is 21% higher ($66.23/54.66) and KMP is 18.2% higher ($76.36/64.58). This emphasizes the point that KMR does better / the discount decreases when KMP/KMR goes up. This will reverse if KMP/KMR goes down. If I had to pick a direction, I'd say down, so you would want to buy KMP to lose less.

      KMR had a compelling "yield" of 8% at prices under $57.50. KMP had a compelling yield of 7%+ at the August low. Where where you then??? I'd wait for KMR/KMP to get to these yield levels to yield the same but on the new $5 distribution projected in the merger announcement.

      If you can unravel all of the moving parts in the EP takeover and from that figure out that KMP/KMR are a buy/buy/buy you are smarter than I am. Deal won't close until 2012, so I think some of the froth here may send prices lower.

91.63-0.35(-0.38%)Sep 15 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT